internalization is mediated through a novel Cbl/p85/ epsin-1 pathway. Mutated EpoR in primary familial and congenital polycythemia patients cannot activate this pathway, exhibiting excessive Epo signaling. Erythropoietin (Epo) binding to the Epo receptor (EpoR) elicits downstream signaling that is essential for red blood cell production. One important negative regulatory mechanism to terminate Epo signaling is Epo-inducedEpoR endocytosis and degradation. Defects in this mechanism play a key role in the overproduction of erythrocytes in primary familial and congenital polycythemia (PFCP). Here we have identified a novel mechanism mediating Epo-dependent EpoR internalization. Epo induces Cbl-dependent ubiquitination of the p85 regulatory sub...
Terminal erythroid differentiation is a precisely regulated process, in which mature red blood cells...
All red blood cells, erythrocytes, originate in bone marrow. The process of their differentiation an...
<div><p>Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: <...
Erythropoietin (EPO) is the primary cytokine regulator of erythropoiesis. Fundamental to this action...
Erythropoietin (EPO) is the primary cytokine regulator of erythropoiesis. Fundamental to this action...
1. Epo-induced EpoR internalization is mediated through a novel Cbl/p85/epsin-1 pathway. 2. Mutated ...
Abstract BACKGROUND: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the ma...
Background: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause o...
Background: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause o...
Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause of primary he...
Primary familial and congenital polycythaemia (PFCP) is a disease characterized by increased red blo...
Abstract BACKGROUND: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the ma...
Abstract BACKGROUND: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the ma...
) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-...
) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-...
Terminal erythroid differentiation is a precisely regulated process, in which mature red blood cells...
All red blood cells, erythrocytes, originate in bone marrow. The process of their differentiation an...
<div><p>Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: <...
Erythropoietin (EPO) is the primary cytokine regulator of erythropoiesis. Fundamental to this action...
Erythropoietin (EPO) is the primary cytokine regulator of erythropoiesis. Fundamental to this action...
1. Epo-induced EpoR internalization is mediated through a novel Cbl/p85/epsin-1 pathway. 2. Mutated ...
Abstract BACKGROUND: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the ma...
Background: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause o...
Background: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause o...
Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause of primary he...
Primary familial and congenital polycythaemia (PFCP) is a disease characterized by increased red blo...
Abstract BACKGROUND: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the ma...
Abstract BACKGROUND: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the ma...
) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-...
) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-...
Terminal erythroid differentiation is a precisely regulated process, in which mature red blood cells...
All red blood cells, erythrocytes, originate in bone marrow. The process of their differentiation an...
<div><p>Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: <...